港股午評:恆指漲0.46% 內房股大漲 CRO板塊反彈
格隆匯9月15日丨港股三大指數午盤集體收漲,恆指漲0.46%,國指漲0.63%,恆生科技指數漲0.2%。 南下資金半日淨流入24.24億港元,大市成交額為451億港元。 盤面上,大型科技股多數走強,京東、阿里巴巴、快手、美團均漲約1%,騰訊微漲;受到寬鬆政策頻出提振,內房股集體上揚,碧桂園大漲9%;拜登生物技術行政命令細節落地,CRO板塊反彈,藥明生物漲6.7%;銀行、證券、保險等大金融股走強,其中三大保險股前8月原保費均實現增長,中國平安漲1.7%領漲內險股;建材水泥股、啤酒股、旅遊觀光股、乳製品股、Saas概念股等股走勢活躍。另外,集裝箱運輸業旺季不旺,海運股普跌;電力股、汽車股持續回調;黃金股、光伏股、稀土概念股、教育股、博彩股普跌。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.